×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Companies to watch: Groupon, Boeing, KemPharm and Netflix
Yahoo News UK
Groupon, Boeing, KemPharm and Netflix are the companies to watch.
5 days ago
KemPharm rebrands to Zevra Therapeutics, doubling down on rare disease focus
Medical Marketing and Media
KemPharm's rebranding to Zevra marks its increased focus on the rare diseases space, the company announced.
14 months ago
KemPharm Receives $10M Milestone For FDA Approval Of Azstarys
Contract Pharma
“We continue to work collaboratively with Corium in preparation for the commercial launch of Azstarys,” stated Travis C. Mickle, Ph.D.,...
36 months ago
KemPharm Stock Breaks Out on Clinical Trial Results
Investopedia
KemPharm Stock Breaks Out on Clinical Trial Results ... KemPharm, Inc. (KMPH) shares rose more than 10% by Friday afternoon after the company...
72 months ago
KemPharm inks Apadaz licensing deal with KVK Tech
Drug Delivery Business
KemPharm inks Apadaz licensing deal with KVK Tech ... KemPharm (NSDQ:KMPH) said yesterday it inked a collaborative licensing deal with KVK Tech to...
66 months ago
KemPharm Rebrands as Zevra Therapeutics
Sleep Review
KemPharm's new name, Greek for “zebra,” is the internationally recognized symbol for the rare disease community.
14 months ago
Coralville drug firm KemPharm plans to go public
The Des Moines Register
Coralville drug firm KemPharm plans to go public ... Travis and Christal Mickle founded KemPharm Inc. in 2006 in Coralville. The company develops.
110 months ago
KemPharm's AZSTARYS ADHD Medication Approved by FDA
ADDitude
The FDA has approved a new stimulant ADHD medication from KemPharm called AZSTARYS, a once-daily methylphenidate treatment for patients age six...
37 months ago
Orphazyme meme ends with $13M sale
Fierce Biotech
Having briefly commanded a market cap of $2.7 billion in June 2021, the Danish meme stock is selling its assets to KemPharm for $12.8...
23 months ago
KemPharm Acquires Majority of Orphazyme Assets Under In-Court Restructuring
BioSpace
KemPharm Acquires Majority of Orphazyme Assets Under In-Court Restructuring ... Following a series of bad news and regulatory rejections,...
23 months ago